These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16043165)

  • 21. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
    Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
    Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of plant phosphatidylcholines by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Zabrouskov V; Al-Saad KA; Siems WF; Hill HH; Knowles NR
    Rapid Commun Mass Spectrom; 2001; 15(12):935-40. PubMed ID: 11400199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid analysis by matrix-assisted laser desorption and ionization mass spectrometry: A methodological approach.
    Schiller J; Arnhold J; Benard S; Müller M; Reichl S; Arnold K
    Anal Biochem; 1999 Feb; 267(1):46-56. PubMed ID: 9918654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for monitoring the digestion of phosphatidylcholine by pancreatic phospholipase A(2).
    Petković M; Müller J; Müller M; Schiller J; Arnold K; Arnhold J
    Anal Biochem; 2002 Sep; 308(1):61-70. PubMed ID: 12234464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid analysis of bronchoalveolar lavage fluid (BAL) by MALDI-TOF mass spectrometry and 31P NMR spectroscopy.
    Schiller J; Hammerschmidt S; Wirtz H; Arnhold J; Arnold K
    Chem Phys Lipids; 2001 Jul; 112(1):67-79. PubMed ID: 11518574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matrix-assisted laser desorption and ionization time-of-flight (MALDI-TOF) mass spectrometry in lipid and phospholipid research.
    Schiller J; Süss R; Arnhold J; Fuchs B; Lessig J; Müller M; Petković M; Spalteholz H; Zschörnig O; Arnold K
    Prog Lipid Res; 2004 Sep; 43(5):449-88. PubMed ID: 15458815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dynamic inflammatory profile of pregnancy can be monitored using a novel lipid-based mass spectrometry technique.
    Rees A; Edwards-I-Coll Z; Richards O; Raikes ME; Angelini R; Thornton CA
    Mol Omics; 2023 May; 19(4):340-350. PubMed ID: 36883215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistence of interleukin 7 activity and levels on tumour necrosis factor alpha blockade in patients with rheumatoid arthritis.
    van Roon JA; Hartgring SA; Wenting-van Wijk M; Jacobs KM; Tak PP; Bijlsma JW; Lafeber FP
    Ann Rheum Dis; 2007 May; 66(5):664-9. PubMed ID: 17185327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor necrosis factor (TNF) inhibitor therapy for rheumatoid arthritis.
    Segal B; Rhodus NL; Patel K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):778-87. PubMed ID: 18930662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphatidylcholine and lysophosphatidylcholine in intestinal mucus of ulcerative colitis patients. A quantitative approach by nanoElectrospray-tandem mass spectrometry.
    Ehehalt R; Wagenblast J; Erben G; Lehmann WD; Hinz U; Merle U; Stremmel W
    Scand J Gastroenterol; 2004 Aug; 39(8):737-42. PubMed ID: 15513358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiating the efficacy of tumor necrosis factor inhibitors.
    Haraoui B
    J Rheumatol Suppl; 2005 Mar; 74():3-7. PubMed ID: 15742457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents.
    Finckh A; Ciurea A; Brulhart L; Kyburz D; Möller B; Dehler S; Revaz S; Dudler J; Gabay C;
    Arthritis Rheum; 2007 May; 56(5):1417-23. PubMed ID: 17469098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic resonance imaging quantification of hand synovitis in patients with rheumatoid arthritis treated with adalimumab.
    Zikou AK; Argyropoulou MI; Voulgari PV; Xydis VG; Nikas SN; Efremidis SC; Drosos AA
    J Rheumatol; 2006 Feb; 33(2):219-23. PubMed ID: 16465650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti-tumor necrosis factor therapy in rheumatoid arthritis.
    Straub RH; Pongratz G; Cutolo M; Wijbrandts CA; Baeten D; Fleck M; Atzeni F; Grunke M; Kalden JR; Schölmerich J; Lorenz HM; Tak PP; Sarzi-Puttini P
    Arthritis Rheum; 2008 Apr; 58(4):976-84. PubMed ID: 18383357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of phosphatidylcholine oxidation products in human plasma using quadrupole time-of-flight mass spectrometry.
    Adachi J; Asano M; Yoshioka N; Nushida H; Ueno Y
    Kobe J Med Sci; 2006; 52(5):127-40. PubMed ID: 17006053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lysophosphatidylethanolamine is - in contrast to - choline - generated under in vivo conditions exclusively by phospholipase A2 but not by hypochlorous acid.
    Schober C; Schiller J; Pinker F; Hengstler JG; Fuchs B
    Bioorg Chem; 2009 Dec; 37(6):202-10. PubMed ID: 19818468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined Use of MALDI-TOF Mass Spectrometry and
    Schröter J; Popkova Y; Süß R; Schiller J
    Methods Mol Biol; 2017; 1609():107-122. PubMed ID: 28660578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polystyrene spheres-assisted matrix-assisted laser desorption ionization mass spectrometry for quantitative analysis of plasma lysophosphatidylcholines.
    Wei Y; Li S; Wang J; Shu C; Liu J; Xiong S; Song J; Zhang J; Zhao Z
    Anal Chem; 2013 May; 85(9):4729-34. PubMed ID: 23574540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptide hormones and histamine in plasma and synovial fluid of patients with rheumatoid arthritis and osteoarthrosis.
    Rovensky J; Imrich R; Radikova Z; Simorova E; Greguska O; Vigas M; Macho L
    Endocr Regul; 2005 Jan; 39(1):1-6. PubMed ID: 16107132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis.
    Van Doornum S; McColl G; Wicks IP
    Rheumatology (Oxford); 2005 Nov; 44(11):1428-32. PubMed ID: 16076882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.